Hongxia Lin

565 total citations
9 papers, 464 citations indexed

About

Hongxia Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmaceutical Science. According to data from OpenAlex, Hongxia Lin has authored 9 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmaceutical Science. Recurrent topics in Hongxia Lin's work include Drug Transport and Resistance Mechanisms (4 papers), Advanced Drug Delivery Systems (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Hongxia Lin is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Advanced Drug Delivery Systems (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Hongxia Lin collaborates with scholars based in South Korea, Germany and United States. Hongxia Lin's co-authors include Dae‐Duk Kim, Chang‐Koo Shim, Hwan‐Jung Roh, Minki Lee, Shengjie Bian, Suk‐Jae Chung, Suk-Jae Chung, Min‐Koo Choi, Hyun‐Jong Cho and Fude Cui and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Journal of Pharmacy and Pharmacology.

In The Last Decade

Hongxia Lin

8 papers receiving 451 citations

Peers

Hongxia Lin

PS

PRM

MB

ONCOL

BIOMA

Kai Dong China

Alaa S. Tulbah Saudi Arabia

Blenda Wong Hong Kong

Michele Pozzoli Australia

Tuo Meng United States

Minki Lee South Korea

Wenquan Liang China

Luka Peternel Slovenia

Hirokazu Katayama Japan

Ziyi Hu China

Kai Dong China

Hongxia Lin

105 ×0.7

PS

65 ×0.5

PRM

176 ×1.5

MB

57 ×0.7

ONCOL

77 ×1.1

BIOMA

Citations per year, relative to Hongxia Lin Hongxia Lin (= 1×) peers Kai Dong

Countries citing papers authored by Hongxia Lin

Since Specialization

Citations

This map shows the geographic impact of Hongxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Lin more than expected).

Fields of papers citing papers by Hongxia Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Lin. The network helps show where Hongxia Lin may publish in the future.

Co-authorship network of co-authors of Hongxia Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Lin. A scholar is included among the top collaborators of Hongxia Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Lin. Hongxia Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chen, Ping, Hongxia Lin, Yongjun Xue, et al.. (2025). A population pharmacokinetic analysis to evaluate the impact of renal impairment on the pharmacokinetics of iberdomide. Journal of Pharmaceutical Sciences. 114(2). 1315–1325.

2.

Wu, Tien‐Yuan, Ying Huang, Chengyue Zhang, et al.. (2015). Pharmacokinetics and pharmacodynamics of 3,3′-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes. Journal of Pharmacokinetics and Pharmacodynamics. 42(4). 401–408. 13 indexed citations

3.

Cho, Hyun‐Jong, Prabagar Balakrishnan, Hongxia Lin, Min‐Koo Choi, & Dae‐Duk Kim. (2012). Application of biopharmaceutics classification system (BCS) in drug transport studies across human respiratory epithelial cell monolayers. Journal of Pharmaceutical Investigation. 42(3). 147–153. 7 indexed citations

4.

Cho, Hyun‐Jong, Min‐Koo Choi, Hongxia Lin, et al.. (2011). Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air–liquid interface method for nasal drug transport study. Journal of Pharmacy and Pharmacology. 63(3). 385–391. 17 indexed citations

5.

Tao, Yang, Fude Cui, Min‐Koo Choi, et al.. (2007). Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability. Drug Delivery. 14(5). 301–308. 112 indexed citations

6.

Lin, Hongxia, et al.. (2006). Enhancing effect of surfactants on fexofenadine·HCl transport across the human nasal epithelial cell monolayer. International Journal of Pharmaceutics. 330(1-2). 23–31. 77 indexed citations

7.

Lin, Hongxia, Hong Li, Hyun‐Jong Cho, et al.. (2006). Air-Liquid Interface (ALI) Culture of Human Bronchial Epithelial Cell Monolayers as an in vitro Model for Airway Drug Transport Studies. Journal of Pharmaceutical Sciences. 96(2). 341–350. 134 indexed citations

8.

Lee, Minki, Jin‐Wook Yoo, Hongxia Lin, et al.. (2005). Air-Liquid Interface Culture of Serially Passaged Human Nasal Epithelial Cell Monolayer forIn VitroDrug Transport Studies. Drug Delivery. 12(5). 305–311. 66 indexed citations

9.

Lin, Hongxia, Jin‐Wook Yoo, Hwan‐Jung Roh, et al.. (2005). Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer. European Journal of Pharmaceutical Sciences. 26(2). 203–210. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact